About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this ...
Glenda Gray, program director of a research consortium, talked with STAT about the impact of the funding freeze on an HIV ...
The previously-unknown condition, dubbed 'post-vaccination syndrome' (PVS), can persist years after taking the jabs - made by ...
Featured artists include local artist Debbie Baxter, whose passion for painting water has taken her far and wide.
12h
Investing News Network on MSNStem Cell Stocks: 10 Biggest NASDAQ Companies in 2025Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...
In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...
mRNA vaccination against SARS-CoV-2 was tied to a 57% and 73% lower risk of having at least one or two long-COVID symptoms, ...
Discovering ultra-conserved elements in the genome and their role in limiting protein production in mice testes.
SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand, with interim results expected by 2026 Joint R&D project between SK and CEPI includes up to ...
23h
Vietnam Investment Review on MSNAIM Vaccine s mRNA Shingles Vaccine Submits Clinical Application to the U SAnother Step Forward in Global Expansion HONG KONG, Feb. 25, 2025 /PRNewswire/ -- As global capital reassesses the investment value of innovative Chinese companies, the development of innovative ...
Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results